COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 120: Articles 1191-1200  | Next

VirNA: a novel Minimum Spanning Networks algorithm for investigating viral evolution
Mazzotti, G., Bianco, L., Lavezzo, E., Bado, M., Fontana, P., Toppo, S.
10.1101/2024.11.05.620028 — Posted: 2024-11-06
Completion of multi-dose COVID-19 vaccines and the associated factors among adolescents and adults in two urban informal settlements in Nairobi, Kenya
Ng'oda, M., Izudi, J., Mwanga, D., Otieno, C., Sanya, R. E., Ziraba, A.
10.1101/2024.11.04.24316733 — Posted: 2024-11-05
Visual preferences for communicating modelling: a study of Covid-19 policy and decision makers
Hadley, L., Rich, C., Tasker, A., Restif, O., Funk, S.
10.1101/2024.11.05.24316774 — Posted: 2024-11-05
Cohort profile: design and methods for Project HERCULES (Healthcare Exemplar for Recovery from COVID 19 by Use of Linear Examination Systems.) Multi-disciplinary implementation and evaluation of an asynchronous review clinic for monitoring chronic eye disease in English NHS services
Muhundhakumar, D., Clarke, C. S., Mills, G., Ramsay, A. I. G., Sailer, K., Scully, P., Wilson, D., Fu, D. J., Ndwandwe, S., Pachilova, R., Symons, A., Napier, S., Adesanya, J., Gazzard, G., Hamilton, R., Wilson, J., Webster, P., Khaw, P. T., Sivaprasad, S., Jayaram, H., Foster, P. J.
10.1101/2024.11.05.24316762 — Posted: 2024-11-05
Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States
Feldstein, L. R., Ruffin, J., Wiegand, R., James-Gist, J., Babu, T. M., Borkowf, C. B., Briggs-Hagen, M., Chappell, J., Chu, H. Y., Englund, J. A., Kuntz, J. L., Lauring, A. S., Lo, N., Carone, M., Lockwood, C., Martin, E. T., Midgley, C. M., Monto, A. S., Naleway, A. L., Ogilvie, T., Saydah, S., Schmidt, M. A., Schmitz, J. E., Smith, N., Sohn, I., Starita, L., Talbot, H. K., Weil, A. A., Grijalva, C. G.
10.1101/2024.11.01.24316597 — Posted: 2024-11-05
An institutional COVID-19 initiative: creation of a biobank and serological data analysis in pre- and post-vaccination cohorts
Fernandes-Siqueira, L. O., Melo, R. R. A., Wermelinger, L. S., Almeida, F. C. L., Salmon, D., Ferreira, G. C., Da Poian, A. T.
10.1101/2024.11.05.24316633 — Posted: 2024-11-05
Direct lipid interactions control SARS-CoV-2 M protein conformational dynamics and virus assembly
Dutta, M., Dolan, K. A., Amiar, S., Bass, E. J., Sultana, R., Voth, G. A., Stahelin, R. V., Brohawn, S. G.
10.1101/2024.11.04.620124 — Posted: 2024-11-05
Neutralizing antibody evasion of SARS-CoV-2 JN.1 derivatives KP.3, KP.3.1.1, LB.1, and XEC
Sano, K., Miyakawa, K., Kato, H., Kimura, Y., Goto, A., Ryo, A., Watanabe, S., Hasegawa, H.
10.1101/2024.11.04.621772 — Posted: 2024-11-05
Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein
Cuypers, M.-L., Jaspers, T., Clerckx, J., Leekens, S., Cawthorne, C., Bormans, G., Cleeren, F., Geukens, N., De Strooper, B., Dewilde, M.
10.1101/2024.11.04.621218 — Posted: 2024-11-05
Sex differences in ACE2, TMPRSS2, and HLA-DQA2 expression in gray matter: Implications for post-COVID-19 neurological symptoms
Kesler, S. R., Schutz, A. D., Franco-Rocha, O. Y., Lewis, K.
10.1101/2024.11.04.24316706 — Posted: 2024-11-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).